Page last updated: 2024-08-24

1,5-anhydroglucitol and Ischemic Attack, Transient

1,5-anhydroglucitol has been researched along with Ischemic Attack, Transient in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujikawa, Y; Kanaya, Y; Kuriyama, M; Nishigaki, M; Shiga, Y; Shimoe, Y; Takamatsu, K; Takemaru, M; Takeshima, S	1

Other Studies

1 other study(ies) available for 1,5-anhydroglucitol and Ischemic Attack, Transient

Article	Year
Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes. Cerebrovascular diseases (Basel, Switzerland), 2017, Volume: 44, Issue:5-6 Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Electronic Health Records; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stroke; Time Factors	2017

Article

Year

Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.

Cerebrovascular diseases (Basel, Switzerland), 2017, Volume: 44, Issue:5-6

Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Electronic Health Records; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stroke; Time Factors

2017